Meridian Medical Technologies
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals, Medical devices |
| Predecessor | Brunswick Biomedical Corporation |
| Founded | 1968 |
| Headquarters | Bridgeton, Missouri , United States |
| Products | Chemical weapon antidotes, autoinjectors (including EpiPen) |
| Parent | Altaris Capital Partners, LLC |
Meridian Medical Technologies, LLC is a U.S.-based firm dedicated to the creation and production of chemical weapon antidotes.
Originally established in 1968 under the name Brunswick Biomedical Corporation, the company adopted the Meridian Medical Technologies name in November 1996 after merging with Survival Technology, Inc. Notably, Survival Technology employed Sheldon Kaplan, who developed several autoinjectors, including the epinephrine autoinjector known as the EpiPen. The EpiPen has been distributed by Dey LP, a subsidiary of Merck KGaA.
In 2003, King Pharmaceuticals acquired Meridian. Subsequently, Meridian became part of Pfizer following Pfizer’s acquisition of King Pharmaceuticals in 2011.
Meridian participates in the Alliance for Biosecurity, an organization committed to addressing and managing serious infectious diseases that threaten global safety.
Altaris Capital Partners, LLC reached an agreement to purchase Meridian from Pfizer in November 2021, finalizing the transaction in January 2022. Later, in November 2022, Altaris revealed intentions to merge Meridian with Kindeva Drug Delivery, another company within its portfolio.
Currently, Meridian is preparing to broaden its operations in Bridgeton, Missouri by introducing additional manufacturing lines.